Skip to main content
TipRanks
Go Ultimate75% OFF

Duopharma Biotech Bhd. (7148) Ownership - Who Owns Duopharma Biotech Bhd.?

Duopharma Biotech Bhd. (7148) Ownership Overview

  • 0.09% ETFs
  • 99.91% Public Companies and Individual Investors

The ownership structure of Duopharma Biotech Bhd. (MY:7148) stock is a mix of institutional, retail, and individual investors. Approximately 0.09% of the company’s stock is owned by Institutional Investors, and 99.91% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

MY:7148 top shareholders
Holder# of SharesType% HoldingValue
Dimensional863,819Institution0.09%232,367
Avantis10,630Institution<0.01%2,859

Top ETF Holders

MY:7148 top ETF holders
Holder# of SharesType% HoldingValue
Dimensional Emerging Markets Core Equity 2 ETF, DFEM ETF546,994Institution0.06%144,301
Dimensional World ex U.S. Core Equity 2 ETF, DFAX ETF315,284Institution0.03%83,174
Avantis Emerging Markets Equity ETF, AVEM ETF10,630Institution<0.01%2,801
Dimensional Emerging Markets ex China Core Equity ETF, DEXC ETF1,000Institution<0.01%264
Dimensional Emerging Core Equity Market ETF, DFAE ETF541Institution<0.01%143

FAQ

What percentage of Duopharma Biotech Bhd. (MY:7148) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.09% of Duopharma Biotech Bhd. (MY:7148) stock is held by institutional investors.
What percentage of Duopharma Biotech Bhd. (MY:7148) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.91% of Duopharma Biotech Bhd. (MY:7148) stock is held by public companies and individual investors.
Who owns the most shares of Duopharma Biotech Bhd. (MY:7148)?
Dimensional owns the most shares of Duopharma Biotech Bhd. (MY:7148).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.